Lyka Labs files Q2 FY27 dematerialisation compliance certificate

Compliance View source PDF Explain this filing

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹72.50

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+0.7% vs market

Pharmaceuticals peers, median of 168sector-0.2%+1.1% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0+0.3+0.7-0.2+1.1

Next day

+0.5+1.1-0.7-0.3+0.8

+4.6+1.3+3.3-0.4+5.0

+9.8+2.0+7.8-0.7+10.5

+15.3+0.3+15.0-1.2+16.5

+21.1+1.1+20.0-1.0+22.0

+16.3-3.2+19.5-4.2+20.5

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lyka Labs submitted a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. Its registrar MUFG Intime India confirmed that securities received from depository participants for dematerialisation were processed within the required timeline, and cancelled certificates were updated in the register of members. No new shares were issued.

Likely market impact

Routine procedural compliance filing; no impact on shareholders or stock price.